Alphasimplex Group, LLC Dexcom Inc Transaction History

Alphasimplex Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$80.99 - $107.93 $53,858 - $71,773	-665 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $12,246 - $16,406	-157 Reduced 19.1%	665 $246,000
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $18,242 - $21,573	191 Added 30.27%	822 $339,000
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $39,551 - $66,469	631 New	631 $256,000
Q1 2020 May 13, 2020	SELL	$47.79 - $75.63 $47,742 - $75,554	-999 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$36.62 - $57.29 $36,583 - $57,232	999 New	999 $219,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Alphasimplex Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Alphasimplex Group, LLC with notifications on news.